The International Alliance for Biological Standardization (IABS) is an independent, non-profit scientific organization,  governed by Articles 60-79 of the Swiss Civil code and by its Constitution. Its office is located in Geneva (Switzerland).

IABS has about 250 members in over 50 countries.

Mission

IABS is devoted to the scientific and medical advancement of biologicals, by facilitating communication among those who develop, produce and regulate biological products for human and animal health.

Objectives

• To provide a unique platform for discussion and the development of consensus positions on contemporary issues related to biologicals;
• To create an ongoing interface among leaders in clinical and basic research, biological product development, public health, manufacturing and regulation, by organizing scientific conferences and publishing reports of such meetings;
• To facilitate the establishment of international reference materials and the formulation of international guidance documents for biological substances used in human and veterinary medicine, through its conferences and publications;
• To promote uniform methods for establishing the international quality of biological products;
• To encourage research in connection with the characterization, standardization, quality, production, and clinical use of biological products.

History

IABS was founded in Lyon, France, in 1955 by a group of independent experts who believed that such an organization could provide a forum where data could be discussed among scientists working in research, development, production, standardization and regulation of human and veterinary biological products with the ultimate aim of using sound scientific data to improve the quality of biological products and their regulation.